InvestorsHub Logo
Followers 60
Posts 3858
Boards Moderated 0
Alias Born 05/25/2021

Re: None

Wednesday, 07/12/2023 3:17:51 PM

Wednesday, July 12, 2023 3:17:51 PM

Post# of 699968
An article from Israel Lowy, Senior Vice President of Translational and Clinical Oncology at Regeneron
Last time I knew Regeneron was a player who came late to the oncology field. All of sudden he is talking about Regeneron will be the leader in using combination approaches to treat cancer. Where did he get the confidence?



https://endpts.com/sp/immuno-oncology-2-0-how-regeneron-is-utilizing-its-expertise-in-antibodies-to-lead-the-next-wave-of-combinatorial-approaches-in-cancer-care/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News